MedPath

Contrast-enhanced Ultrasound in the Treatment of Acute Spinal Cord Injury

Phase 4
Recruiting
Conditions
Acute Spinal Cord Injury
Interventions
Registration Number
NCT06654804
Lead Sponsor
University of Washington
Brief Summary

Patients with traumatic spinal cord injury (tSCI) often suffer from spinal cord swelling inside the thecal sac, which contains the spinal cord and surrounding fluid, leading to increased pressure on the spinal cord tissue and decreased spinal cord blood flow at the site of injury. The combination of increased pressure and decreased blood flow causes vascular hypoperfusion of the spinal cord and exacerbates the severity of injury. This is also referred to as secondary injury. Thus, knowledge of spinal cord hypoperfusion would allow the treating physician to optimize the hemodynamic condition of the patient with acute spinal cord injury and potentially improve functional outcomes.

Detailed Description

The investigators plan to use contrast-enhanced ultrasound (CEUS) to determine a decrease in the blood flow in the spinal cord at the site of injury, during the routine surgery that these patients require to decompress and stabilize their injured spine. This may help the investigators to determine the efficacy of certain treatments in improving blood flow and patients suffering from traumatic spinal cord injury.

Patients presenting to Harborview Medical Center with a diagnosis of traumatic spinal cord injury will be screened for participation. Many of these patients require emergent or urgent surgery for decompression of the spinal cord and stabilization of the spine.

The patient will be taken to the operating room as per routine. After completion of the key elements of surgery, namely posterior decompression, and stabilization of the cervical or thoracic spinal cord, CEUS will be performed. Importantly, the proposed trial does not prolong the time before surgical decompression and stabilization are accomplished. Moreover, it does not increase the invasiveness of the procedure as it is collected at the final stage of the routine procedure. A hand-held intraoperative ultrasound probe will be used to collect sagittal images of the spinal cord centered above the spinal cord injury. A bolus IV injection of the contrast agent will be given. Continuous imaging will be obtained to record contrast inflow and washout.

Post-operatively, the participant will receive routine MRI imaging within one week (health status permitting) and one year.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • 18 years of age minimum
  • Acute spinal cord injury fpr less than 24 hours
  • Injury ranging from mild spinal cord injury where motor function is preserved (AIS A) to complete injury where there is no motor or sensory function below the leel of the injury (AIS D)
  • Medically stable to undergo routine dorsal decompression, spinal realignment
  • and stabilizing with segmental instrumentation
Read More
Exclusion Criteria
  • Younger than 18 years old
  • Neurological lower extremity exam missing or intact
  • Traumatic head injury with a Glasgow score of 11 or lower
  • Cord injury level caudal to T10 (thoracic spine level 10)
  • A known sensitivity to lipid microsphere or its components, such as polyethylene glycol (PEG)
  • A history of anaphylactoid reactions from ultrasound enhancing agents
  • A known history of cardiopulmonary conditions
  • Cardiac shunt
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Contrast-enhanced ultrasound in traumatic spinal cord injuryPerflutren lipidA bolus IV injection of Perflutren lipid contrast agent will be given. Continuous imaging will be obtained.
Primary Outcome Measures
NameTimeMethod
Establish acquisition and validity of intraoperative CEUS biomarker for acute human tSCI and surgical outcomes of the population recieveing the intra-operative contrast enhancing biomarker and ultrasound during spinal cord injury repair surgery.Two years

Patients with traumatic spinal cord injury (tSCI) often suffer from spinal cord swelling inside the thecal sac, which contains the spinal cord and surrounding fluid, leading to increased pressure on the spinal cord tissue and decreased spinal cord blood flow at the site of injury. The combination of increased pressure and decreased blood flow causes vascular hypoperfusion of the spinal cord and exacerbates the severity of injury. This is also referred to as secondary injury. Thus, knowledge of spinal cord hypoperfusion would allow the treating physician to optimize the hemodynamic condition of patient with acute spinal cord injury and potentially improve functional outcome. We plan to use contrast-enhanced ultrasound (CEUS) to determine decrease of blood flow in the spinal cord at the site of injury, during the routine surgery that these patients require to decompress and stabilize their injured spine.

Secondary Outcome Measures
NameTimeMethod
Determine the prognostic capacity of CEUS biomarker for acute tSCI and surgical outcomes/recovery in spine injury/surgery.Two years

Measure the outcomes of spinal cord decompression surgery in patient population.

The protocol is designed to develop a standardized operating procedure for prognostic intraoperative biomarker acquisition and readout. Inter- and intra-rater reliability will be scored, and the CEUS markers will be validated with tSCI severity reference standards such as MRI biomarkers and AIS score. Aim 2 of the study will also focus on determining the prognostic capacity for chronic neurological outcome.

Trial Locations

Locations (1)

University of Washington Harborview Medical Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath